Anxiety and/or depression Mental and Behavioural Disorders Anxiety disorder, unspecified, Depression NOS
Conditions
Interventions
Current interventions as of 27/11/2023:
This is a cluster randomised trial, so randomisation will take place at the service level. Half (11) of the services will be allocated to the intervention arm a
Sponsors
University of Manchester
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: Current participant inclusion criteria as of 11/02/2022: Services: 1. Any IAPT service (NHS or third sector) that supports patients at Step 2 over the telephone will be eligible 2. Services will need to be providing at least 20% of their treatment sessions using the telephone and have enough referrals likely to allow for a sample of 100 patients for the enriched sample 3. Multiple IAPT services within the same Trust will be included if they work independently to each other Professionals: All professionals working within the IAPT teams in services that are recruited will be eligible to take part (Service Leads, Managers, Psychological Wellbeing Practitioners (PWPs), Administrators) Patients: Patients will be recruited via the services that are recruited into the trial. Patients who meet the following criteria 1-3 below will be eligible. 1. Adults aged 18+ years 2. Experiencing anxiety and/or depression 3. All patients who are allocated to receive telephone therapy _____ Previous participant inclusion criteria: Services: 1. Any IAPT service (NHS or third sector) that supports patients at Step 2 over the telephone will be eligible 2. Services will need to be providing at least 20% of their treatment sessions using the telephone and have enough referrals likely to allow for a sample of 100 patients for the enriched sample 3. Multiple IAPT services within the same Trust will be included if they work independently to each other Professionals: All professionals working within the IAPT teams will be eligible to take part (Service Leads, Managers, Psychological Wellbeing Practitioners (PWPs), Administrators) Patients: 1. Adults aged 18+ years 2. Experiencing anxiety and/or depression 3. All patients who are allocated to receive telephone therapy
Exclusion criteria
Exclusion criteria: Current exclusion criteria as of 27/11/2023: Services: IAPT sites where telephone referral level would feasibly generate a participant sample of 100 over a period of up to 6-9 months. Patients: Does not meet inclusion criteria Professionals – workshop and training sample: No individuals working within the IAPT teams will be excluded from taking part. The decision as to whether to attend will be made by individuals or the sites (who may have to take into account practitioner workloads etc). Professionals – post-intervention qualitative interviews/discussion groups: No individuals who attended the workshop or training will be excluded from taking part in an interview, the decision to take part will be for each individual to make. Previous exclusion criteria: Services: IAPT sites where telephone referral level would feasibly generate a participant sample of 100 over a period of up to 6 months. Patients: Does not meet inclusion criteria Professionals – workshop and training sample: No individuals working within the IAPT teams will be excluded from taking part. The decision as to whether to attend will be made by individuals or the sites (who may have to take into account practitioner workloads etc). Professionals – post-intervention qualitative interviews/discussion groups: No individuals who attended the workshop or training will be excluded from taking part in an interview, the decision to take part will be for each individual to make.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Depression measured using the Patient Health Questionnaire 9 (PHQ-9) at baseline, 6 and 12 months 2. Anxiety measured using General Anxiety Disorder-7 (GAD-7) at baseline, 6 and 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Current secondary outcome measures as of 14/10/2021: 1. Treatment engagement and cost-effectiveness of treatment measured using the EQ-5D-5L and Economic Patient Questionnaire (EPQ) at 6 and 12 months 2. Patient-therapist relationships measured using the Agnew Relationship Measure (ARM-5) at 6 months 3. Acceptability of the EQUITy intervention to patients and professionals (Psychological Wellbeing Practitioners (PWPs), service leads, managers, supervisors) will be collected via qualitative interviews and discussion groups (professionals only) at weeks 16-24 Previous secondary outcome measures: 1. Treatment engagement and cost-effectiveness of treatment measured using the EQ-5D-5L and Economic Patient Questionnaire (EPQ) at 6 and 12 months 2. Acceptability of the EQUITy intervention to patients and professionals (Psychological Wellbeing Practitioners (PWPs), service leads, managers, supervisors) will be collected via qualitative interviews and discussion groups (professionals only) at weeks 16-24 | — |
Countries
England, United Kingdom
Contacts
Public ContactJudith Gellatly
Outcome results
None listed